Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.
Description: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: baselineDescription: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: 3 monthsDescription: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients
Measure: Administration of 18F-αvβ6-BP Time: 6 monthsDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: baselineDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: 3 monthsDescription: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET
Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage Time: 6 monthsDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: baselineDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: 3 monthsDescription: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.
Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT. Time: 6 months